Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.28
+0.45 (3.51%)
Nov 3, 2026, 11:53 AM EST - Market open
Alpha Tau Medical Employees
Alpha Tau Medical had 121 employees as of December 31, 2025. The number of employees decreased by 4 or 3.20% compared to the previous year. That makes Alpha Tau Medical the 30,242nd largest employer in the world and 3,875th in the United States.
Employees
121
Change (1Y)
-4
Growth (1Y)
-3.20%
Revenue / Employee
n/a
Profits / Employee
-$765,074
Market Cap
1.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 121 | -4 | -3.20% |
| Dec 31, 2024 | 125 | 4 | 3.31% |
| Dec 31, 2023 | 121 | 27 | 28.72% |
| Dec 31, 2022 | 94 | 11 | 13.25% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| MannKind | 592 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Verastem | 102 |
| Silence Therapeutics | 88 |
| Vor Biopharma | 76 |
| Savara | 70 |
DRTS News
- 5 days ago - Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange - GlobeNewsWire
- 12 days ago - Alpha Tau signs MOU with Samsung Medical Center in Seoul - TheFly
- 12 days ago - Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea - GlobeNewsWire
- 15 days ago - Alpha Tau announces FDA approval of REGAIN trial IDE supplement - TheFly
- 15 days ago - Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting - GlobeNewsWire
- 4 weeks ago - Alpha Tau to Participate in October Investor Conferences - GlobeNewsWire
- 2 months ago - Alpha Tau price target raised to $30 from $17 at Barclays - TheFly
- 2 months ago - Alpha Tau to Participate in September Investor Conferences - GlobeNewsWire